Global Prevalence of Adaptive and Prolonged Infections’ Mutations in the Receptor-Binding Domain of the SARS-CoV-2 Spike Protein
Several vaccines with varying efficacies have been developed and are currently administered globally to minimize the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Despite having an RNA-dependent RNA polymerase with a proofreading activity, new variants of SARS-CoV-2 are on...
Main Authors: | Johan Lennerstrand, Navaneethan Palanisamy |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-09-01
|
Series: | Viruses |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4915/13/10/1974 |
Similar Items
-
SARS-CoV-2 variants of concern and spike protein mutational dynamics in a Swedish cohort during 2021, studied by Nanopore sequencing
by: Steinar Mannsverk, et al.
Published: (2022-10-01) -
Prevalence of SARS-CoV-2 Omicron Sublineages and Spike Protein Mutations Conferring Resistance against Monoclonal Antibodies in a Swedish Cohort during 2022–2023
by: Jonathan Haars, et al.
Published: (2023-09-01) -
Humoral responses to the SARS-CoV-2 spike and receptor binding domain in context of pre-existing immunity confer broad sarbecovirus neutralization
by: Blake M. Hauser, et al.
Published: (2022-08-01) -
Evidence of a putative glycosaminoglycan binding site on the glycosylated SARS-CoV-2 spike protein N-terminal domain
by: Zachariah P. Schuurs, et al.
Published: (2021-01-01) -
Advances in SARS-CoV-2 receptor-binding domain-based COVID-19 vaccines
by: Xiaoqing Guan, et al.
Published: (2023-12-01)